Proteomics International Laboratories Ltd, a pioneer in predictive diagnostics, is pleased to advise that it has received firm commitments for a share placement to raise $8 million (before costs) through the issue of 9.41 million shares in the Company (the “Placement”).
The Placement was heavily oversubscribed, supported by Australian-based institutions, and sophisticated and professional investors.
Funds from the Placement (after costs) will be used for:
